Novel Pyridone Carboxamide Derived Compounds as Soluble Epoxide Hydrolase Inhibitors for Treating Diabetic Retinopathy

Provided herein are novel pyridone carboxamide derived compounds as soluble epoxide hydrolase inhibitors, pharmaceutical compositions, use of such compounds in treating diabetic retinopathy, and processes for preparing such compounds.

Authors

Ram W. Sabnis (ORCID: https://orcid.org/0000-0001-7289-0581)

Publication Details

Journal: ACS Medicinal Chemistry Letters
Published: 2026-04-01
DOI: https://doi.org/10.1021/acsmedchemlett.6c00162
Primary Topic: Eicosanoids and Hypertension Pharmacology
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Novel Pyridone Carboxamide Derived Compounds as Soluble Epoxide Hydrolase Inhibitors for Treating Diabetic Retinopathy

Ram W. Sabnis

Apr 1, 2026

ACS Medicinal Chemistry Letters

Eicosanoids and Hypertension Pharmacology

article

Novel Pyridone Carboxamide Derived Compounds as Soluble Epoxide Hydrolase Inhibitors for Treating Diabetic Retinopathy

Ram W. Sabnis

April 1, 2026article en

Abstract

ACS Medicinal Chemistry LettersVol. 17(4)

Openalex Percentile: Top 27%

Eicosanoids and Hypertension Pharmacology

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Novel Pyridone Carboxamide Derived Compounds as Soluble Epoxide Hydrolase Inhibitors for Treating Diabetic Retinopathy — Ram W. Sabnis · ACS Medicinal Chemistry Letters (2026) | TGRS Research Map | TGRS